Biogen Idec is taking advantage of advances in the study of protein-protein interactions to generate the first comprehensive human interactome. In collaboration with Harvard Medical School researchers, the company will map the interaction network of 10,000-15,000 human proteins over the next 4 years, which could provide Biogen with a wealth of new targets in immunological and neurological diseases.